Regulation of tenascin expression in bone

Journal of Cellular Biochemistry

Volumn 112, Issue 11, 2011, Pages 3354-3363

  Morgan, Jessica M ^a   Wong, Alice ^a   Yellowley, Clare E ^a   Genetos, Damian C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

bone morphogenetic protein; MAPK; mechanotransduction; osteoblast; osteocyte; tenascin; Wnt

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; TENASCIN; TENASCIN W; UNCLASSIFIED DRUG; WNT5A PROTEIN;

ANIMAL CELL; ARTICLE; BONE; CELL DIFFERENTIATION; CONTROLLED STUDY; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, WESTERN; BONE AND BONES; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINE; MECHANOTRANSDUCTION, CELLULAR; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NFATC TRANSCRIPTION FACTORS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TENASCIN; TYPE C PHOSPHOLIPASES; WNT PROTEINS;

EID: 80054968751     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23265     Document Type: Article

References (57)

1. Alford AI, Hankenson KD,. 2006. Matricellular proteins: Extracellular modulators of bone development, remodeling, and regeneration. Bone 38: 749-757. (Pubitemid 44498588)
2. Arnsdorf EJ, Tummala P, Jacobs CR,. 2009. Non-canonical Wnt signaling and N-cadherin related beta-catenin signaling play a role in mechanically induced osteogenic cell fate. PLoS ONE 4: e5388.
3. Axelrad TW, Einhorn TA,. 2009. Bone morphogenetic proteins in orthopaedic surgery. Cytokine Growth Factor Rev 20: 481-488.
4. Bristow J, Carey W, Egging D, Schalkwijk J,. 2005. Tenascin-X, collagen, elastin, and the Ehlers-Danlos syndrome. Am J Med Genet C 139C: 24-30. (Pubitemid 41739244)
5. Burch GH, Gong Y, Liu W, Dettman RW, Curry CJ, Smith L, Miller WL, Bristow J,. 1997. Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat Genet 17: 104-108. (Pubitemid 27377542)
6. Chiquet M, Sarasa-Renedo A, TunÃ-Civelek V,. 2004. Induction of tenascin-C by cyclic tensile strain versus growth factors: Distinct contributions by Rho/ROCK and MAPK signaling pathways. Biochim Biophys Acta 1693: 193-204. (Pubitemid 39195237)
7. Chiquet-Ehrismann R,. 2004. Tenascins. Int J Biochem Cell Biol 36: 986-990. (Pubitemid 38501550)
8. Chiquet-Ehrismann R, Chiquet M,. 2003. Tenascins: Regulation and putative functions during pathological stress. J Pathol 200: 488-499. (Pubitemid 36818249)
9. Cohen ED, Ihida-Stansbury K, Lu MM, Panettieri RA, Jones PL, Morrisey EE,. 2009. Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/PDGFR pathway. J Clin Invest 119: 2538-2549.
10. Fluck M, Tunc-Civelek V, Chiquet M,. 2000. Rapid and reciprocal regulation of tenascin-C and tenascin-Y expression by loading of skeletal muscle. J Cell Sci 113: 3583-3591.
11. Frangos JA, McIntire LV, Eskin SG,. 1988. Shear stress induced stimulation of mammalian cell metabolism. Biotechnol Bioeng 32: 1053-1060.
12. Genetos DC, Wong A, Watari S, Yellowley CE,. 2010. Hypoxia increases annexin A2 expression in osteoblastic cells via VEGF and ERK. Bone 47: 1013-1019.
13. Ghatnekar A, Trojanowska M,. 2008. GATA-6 is a novel transcriptional repressor of the human Tenascin-C gene expression in fibroblasts. Biochim Biophys Acta 1779: 145-151. (Pubitemid 351381516)
14. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GCM, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Jüppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard M-J, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML,. 2001. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107: 513-523. (Pubitemid 33152786)
15. Guicheux J, Lemonnier J, Ghayor C, Suzuki A, Palmer G, Caverzasio J,. 2003. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J Bone Miner Res 18: 2060-2068. (Pubitemid 37377457)
16. Hasegawa M, Hirata H, Sudo A, Kato K, Kawase D, Kinoshita N, Yoshida T, Uchida A,. 2004. Tenascin-C concentration in synovial fluid correlates with radiographic progression of knee osteoarthritis. J Rheumatol 31: 2021-2026. (Pubitemid 39336729)
17. Hens JR, Wilson KM, Dann P, Chen X, Horowitz MC, Wysolmerski JJ,. 2005. TOPGAL mice show that the canonical Wnt signaling pathway is active during bone development and growth and is activated by mechanical loading in vitro. J Bone Miner Res 20: 1103-1113. (Pubitemid 40863798)
18. Ihida-Stansbury K, McKean DM, Lane KB, Loyd JE, Wheeler LA, Morrell NW, Jones PL,. 2006. Tenascin-C is induced by mutated BMP type II receptors in familial forms of pulmonary arterial hypertension. Am J Phys 291: L694-L702. (Pubitemid 44498481)
19. Jacobs CR, Yellowley CE, Davis BR, Zhou Z, Cimbala JM, Donahue HJ,. 1998. Differential effect of steady versus oscillating flow on bone cells. J Biomech 31: 969-976. (Pubitemid 28561790)
20. Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K,. 2004. Tenascin-C upregulation by transforming growth factor-[beta] in human dermal fibroblasts involves Smad3, Sp1, and Ets1. Oncogene 23: 1656-1667. (Pubitemid 38445158)
21. Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K,. 2006. Upregulation of tenascin-C expression by IL-13 in human dermal fibroblasts via the phosphoinositide 3-kinase/Akt and the protein kinase C signaling pathways. J Invest Dermatol 126: 551-560. (Pubitemid 43255641)
22. Kido S, Kuriwaka-Kido R, Umino-Miyatani Y, Endo I, Inoue D, Taniguchi H, Inoue Y, Imamura T, Matsumoto T,. 2010. Mechanical stress activates Smad pathway through PKC to enhance interleukin-11 gene transcription in osteoblasts. PLoS ONE 5: e13090.
23. Kilian O, Dahse R, Alt V, Zardi L, Hentschel J, Schnettler R, Kosmehl H,. 2008. mRNA expression and protein distribution of fibronectin splice variants and high-molecular weight tenascin-C in different phases of human fracture healing. Calcif Tissue Int 83: 101-111.
24. Kimura H, Akiyama H, Nakamura T, de Crombrugghe B,. 2007. Tenascin-W inhibits proliferation and differentiation of preosteoblasts during endochondral bone formation. Biochem Biophys Res Commun 356: 935-941. (Pubitemid 46553747)
25. Kozawa O, Hatakeyama D, Yoshida M, Kamiya Y, Kondo C, Matsuno H, Uematsu T,. 2001. Activation of p44/p42 mitogen-activated protein kinase limits triiodothyronine-stimulated alkaline phosphatase activity in osteoblasts. Biochem Biophys Res Commun 286: 1140-1143. (Pubitemid 32924888)
26. Kühl M, Sheldahl LC, Park M, Miller JR, Moon RT,. 2000. The Wnt/Ca2+ pathway: A new vertebrate Wnt signaling pathway takes shape. Trends Genet 16: 279-283. (Pubitemid 30389591)
27. Kurihara K, Sato I,. 2004. Distribution of tenascin-C and -X, and soft X-ray analysis of the mandibular symphysis during mandible formation in the human fetus. Okajimas Folia Anat Jpn 81: 49-55. (Pubitemid 39462976)
28. Lau KH, Kapur S, Kesavan C, Baylink DJ,. 2006. Up-regulation of the Wnt, estrogen receptor, insulin-like growth factor-I, and bone morphogenetic protein pathways in C57BL/6J osteoblasts as opposed to C3H/HeJ osteoblasts in part contributes to the differential anabolic response to fluid shear. J Biol Chem 281: 9576-9588. (Pubitemid 43864676)
29. Liu Y, Bodine PV, Billiard J,. 2007. Ror2, a novel modulator of osteogenesis. J Musculoskelet Neuronal Interact 7: 323-324.
30. Luvalle P, Ma Q, Beier F,. 2003. The role of activating transcription factor-2 in skeletal growth control. J Bone Joint Surg Am 85: 133-136. (Pubitemid 36535056)
31. Ma L, Wang H-Y,. 2007. Mitogen-activated protein kinase p38 regulates the Wnt/cyclic GMP/Ca2+ non-canonical pathway. J Biol Chem 282: 28980-28990. (Pubitemid 47606074)
32. Mackie EJ, Ramsey S,. 1996. Modulation of osteoblast behaviour by tenascin. J Cell Sci 109 (Pt 6): 1597-1604. (Pubitemid 26190508)
33. Mackie EJ, Thesleff I, Chiquet-Ehrismann R,. 1987. Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro. J Cell Biol 105: 2569-2579. (Pubitemid 18017687)
34. Marsell R, Einhorn TA,. 2009. The role of endogenous bone morphogenetic proteins in normal skeletal repair. Injury 40: S4-S7.
35. Meloty-Kapella CV, Degen M, Chiquet-Ehrismann R, Tucker RP,. 2008. Effects of tenascin-W on osteoblasts in vitro. Cell Tissue Res 334: 445-455.
36. Mikic B, Wong M, Chiquet M, Hunziker EB,. 2000. Mechanical modulation of tenascin-C and collagen-XII expression during avian synovial joint formation. J Orthop Res 18: 406-415. (Pubitemid 30599616)
37. Mikura A, Okuhara S, Saito M, Ota M, Ueda K, Iseki S,. 2009. Association of tenascin-W expression with mineralization in mouse calvarial development. Congenit Anom (Kyoto) 49: 77-84.
38. Orriss IR, Burnstock G, Arnett TR,. 2010. Purinergic signalling and bone remodelling. Curr Opin Pharmacol 10: 322-330.
39. Patil C, Zhu X, Rossa C, Kim YJ, Kirkwood KL,. 2004. p38 MAPK regulates IL-1β induced IL-6 expression through mRNA stability in osteoblasts. Immunol Invest 33: 213-233. (Pubitemid 38685932)
40. Pazzaglia L, Conti A, Chiechi A, Novello C, Magagnoli G, Astolfi A, Pession A, Krenacs T, Alberghini M, Picci P, Benassi MS,. 2010. Differential gene expression in classic giant cell tumours of bone: Tenascin C as biological risk factor for local relapses and metastases. Histopathology 57: 59-72.
41. Pilbeam CC, Harrison JR, Raisz LG,. 2002. Prostaglandins and bone metabolism In:, Blilezikian JP, Raisz LG, Martin TJ, editors. Principles of bone biology. San Diego: Elsevier, pp 979-994.
42. Robling AG, Castillo AB, Turner CH,. 2006. Biomechanical and molecular regulation of bone remodeling. Annu Rev Biomed Eng 8: 455-498. (Pubitemid 44314825)
43. Scherberich A, Tucker RP, Samandari E, Brown-Luedi M, Martin D, Chiquet-Ehrismann R,. 2004. Murine tenascin-W: A novel mammalian tenascin expressed in kidney and at sites of bone and smooth muscle development. J Cell Sci 117: 571-581. (Pubitemid 38240198)
44. Scherberich A, Tucker RP, Degen M, Brown-Luedi M, Andres AC, Chiquet-Ehrismann R,. 2005. Tenascin-W is found in malignant mammary tumors, promotes alpha8 integrin-dependent motility and requires p38MAPK activity for BMP-2 and TNF-alpha induced expression in vitro. Oncogene 24: 1525-1532. (Pubitemid 40396082)
45. Secreto FJ, Hoeppner LH, Westendorf JJ,. 2009. Wnt signaling during fracture repair. Curr Osteoporos Rep 7: 64-69.
46. Schmittgen TD, Livak KJ,. 2008. Analyzing real-time PCR data by the comparative CT method. Nat Protocols 3: 1101-1108. (Pubitemid 351818697)
47. Urist MR,. 1965. Bone: Formation by autoinduction. Science 150: 893-899.
48. Wan M, Cao X,. 2005. BMP signaling in skeletal development. Biochem Biophys Res Commun 328: 651-657. (Pubitemid 40208302)
49. Webb CM, Zaman G, Mosley JR, Tucker RP, Lanyon LE, Mackie EJ,. 1997. Expression of tenascin-C in bones responding to mechanical load. J Bone Miner Res 12: 52-58. (Pubitemid 27053611)
50. Westendorf JJ, Kahler RA, Schroeder TM,. 2004. Wnt signaling in osteoblasts and bone diseases. Gene 341: 19-39. (Pubitemid 39335880)
51. Wozney JM,. 1992. The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 32: 160-167.
52. Wu CC, Li YS, Haga JH, Wang N, Lian IY, Su FC, Usami S, Chien S,. 2006. Roles of MAP kinases in the regulation of bone matrix gene expressions in human osteoblasts by oscillatory fluid flow. J Cell Biochem 98: 632-641. (Pubitemid 43727180)
53. Yamamoto K, Dang QN, Kennedy SP, Osathanondh R, Kelly RA, Lee RT,. 1999. Induction of tenascin-C in cardiac myocytes by mechanical deformation. J Biol Chem 274: 21840-21846.
54. Yamanaka H, Moriguchi T, Masuyama N, Kusakabe M, Hanafusa H, Takada R, Takada S, Nishida E,. 2002. JNK functions in the non-canonical Wnt pathway to regulate convergent extension movements in vertebrates. EMBO Rep 3: 69-75. (Pubitemid 34144818)
55. Yoshida T, Ishihara A, Hirokawa Y, Kusakabe M, Sakakura T,. 1995. Tenascin in breast cancer development-Is epithelial tenascin a marker for poor prognosis ? Cancer Lett 90: 65-73.
56. You J, Reilly GC, Zhen X, Yellowley CE, Chen Q, Donahue HJ, Jacobs CR,. 2001. Osteopontin gene regulation by oscillatory fluid flow via intracellular calcium mobilization and activation of mitogen-activated protein kinase in MC3T3-E1 osteoblasts. J Biol Chem 276: 13365-13371.
57. Zhao G-Q,. 2003. Consequences of knocking out BMP signaling in the mouse. Genesis 35: 43-56. (Pubitemid 36150981)